BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 11680170)

  • 21. Antisense inhibition of AT1 receptor in vascular smooth muscle cells using adeno-associated virus-based vector.
    Mohuczy D; Gelband CH; Phillips MI
    Hypertension; 1999 Jan; 33(1 Pt 2):354-9. PubMed ID: 9931129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Communication between tyrosine kinase pathway and myosin light chain kinase pathway in smooth muscle.
    Jin N; Siddiqui RA; English D; Rhoades RA
    Am J Physiol; 1996 Oct; 271(4 Pt 2):H1348-55. PubMed ID: 8897927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased myosin light chain kinase expression in hypertension: Regulation by serum response factor via an insertion mutation in the promoter.
    Han YJ; Hu WY; Chernaya O; Antic N; Gu L; Gupta M; Piano M; de Lanerolle P
    Mol Biol Cell; 2006 Sep; 17(9):4039-50. PubMed ID: 16822834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Regulation of hypoxia inducible factor-1α on permeability of vascular endothelial cells and the mechanism].
    Hu DL; Yu YX; Liang R; Zhou SY; Duan SL; Jiang ZY; Meng CY; Jiang W; Wang H; Sun YX; Fang LS
    Zhonghua Shao Shang Za Zhi; 2019 Mar; 35(3):209-217. PubMed ID: 30897868
    [No Abstract]   [Full Text] [Related]  

  • 25. Expression of antisense transcripts encoding an extracellular matrix protein by stably transfected vascular smooth muscle cells.
    Dreher KL; Cowan K
    Eur J Cell Biol; 1991 Feb; 54(1):1-9. PubMed ID: 2032539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of non-kinase activity of myosin light-chain kinase in regulating smooth muscle contraction, a review dedicated to Dr. Setsuro Ebashi.
    Nakamura A; Xie C; Zhang Y; Gao Y; Wang HH; Ye LH; Kishi H; Okagaki T; Yoshiyama S; Hayakawa K; Ishikawa R; Kohama K
    Biochem Biophys Res Commun; 2008 Apr; 369(1):135-43. PubMed ID: 18053800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormonal regulation of a chicken oviduct messenger ribonucleic acid that shares a common domain with gizzard myosin light chain kinase.
    Russo MA; Guerriero V; Means AR
    Mol Endocrinol; 1987 Jan; 1(1):60-7. PubMed ID: 3454871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ontogenesis of myosin light chain kinase mRNA and protein content in guinea pig tracheal smooth muscle.
    Chitano P; Voynow JA; Pozzato V; Cantillana V; Burch LH; Wang L; Murphy TM
    Pediatr Pulmonol; 2004 Dec; 38(6):456-64. PubMed ID: 15376333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulatory effect of Rac1 on vascular reactivity after hemorrhagic shock in rats.
    Li T; Yang G; Xu J; Zhu Y; Liu L
    J Cardiovasc Pharmacol; 2011 Jun; 57(6):656-65. PubMed ID: 21386710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myosin light chain kinase steady-state kinetics: comparison of smooth muscle myosin II and nonmuscle myosin IIB as substrates.
    Alcala DB; Haldeman BD; Brizendine RK; Krenc AK; Baker JE; Rock RS; Cremo CR
    Cell Biochem Funct; 2016 Oct; 34(7):469-474. PubMed ID: 27528075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of monocyte chemoattractant protein-1 by the oxidized lipid, 13-hydroperoxyoctadecadienoic acid, in vascular smooth muscle cells via nuclear factor-kappa B (NF-kappa B).
    Dwarakanath RS; Sahar S; Reddy MA; Castanotto D; Rossi JJ; Natarajan R
    J Mol Cell Cardiol; 2004 Apr; 36(4):585-95. PubMed ID: 15081318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased expression of myosin light chain kinase mRNA is related to metastasis in non-small cell lung cancer.
    Minamiya Y; Nakagawa T; Saito H; Matsuzaki I; Taguchi K; Ito M; Ogawa J
    Tumour Biol; 2005; 26(3):153-7. PubMed ID: 15970650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mitogen-activated protein kinase activation is involved in platelet-derived growth factor-directed migration by vascular smooth muscle cells.
    Graf K; Xi XP; Yang D; Fleck E; Hsueh WA; Law RE
    Hypertension; 1997 Jan; 29(1 Pt 2):334-9. PubMed ID: 9039124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation of cDNA for bovine stomach 155 kDa protein exhibiting myosin light chain kinase activity.
    Kobayashi H; Inoue A; Mikawa T; Kuwayama H; Hotta Y; Masaki T; Ebashi S
    J Biochem; 1992 Dec; 112(6):786-91. PubMed ID: 1284247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for myosin light chain kinase mediating noradrenaline-evoked cation current in rabbit portal vein myocytes.
    Aromolaran AS; Albert AP; Large WA
    J Physiol; 2000 May; 524 Pt 3(Pt 3):853-63. PubMed ID: 10790163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myosin light chain kinase facilitates endocytosis of synaptic vesicles at hippocampal boutons.
    Li L; Wu X; Yue HY; Zhu YC; Xu J
    J Neurochem; 2016 Jul; 138(1):60-73. PubMed ID: 27062289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of DNA sequence and mutant analyses and antisense oligodeoxynucleotides to examine the molecular basis of nonmuscle myosin light chain kinase autoinhibition, calmodulin recognition, and activity.
    Shoemaker MO; Lau W; Shattuck RL; Kwiatkowski AP; Matrisian PE; Guerra-Santos L; Wilson E; Lukas TJ; Van Eldik LJ; Watterson DM
    J Cell Biol; 1990 Sep; 111(3):1107-25. PubMed ID: 2202734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum and platelet-derived growth factor-induced expression of vascular permeability factor mRNA by human vascular smooth muscle cells in vitro.
    Williams B; Quinn-Baker A; Gallacher B
    Clin Sci (Lond); 1995 Feb; 88(2):141-7. PubMed ID: 7720337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracellular interaction of myosin light chain kinase with macrophage migration inhibition factor (MIF) in endothelium.
    Wadgaonkar R; Dudek SM; Zaiman AL; Linz-McGillem L; Verin AD; Nurmukhambetova S; Romer LH; Garcia JG
    J Cell Biochem; 2005 Jul; 95(4):849-58. PubMed ID: 15838879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The mechanism underlying vascular smooth muscle cell apoptosis induced by atorvastatin may be mainly associated with down-regulation of survivin expression.
    Xu YG; Zhou SH; Li YG; Zheng CH; Li XP; Liu QM; Xu DM; Chen S
    Cardiovasc Drugs Ther; 2007 Jun; 21(3):145-53. PubMed ID: 17372815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.